Barclays »

Cardiol Therapeutics Inc- foreign shares owned by Barclays

Quarter-by-quarter ownership of Cardiol Therapeutics Inc- foreign (CRDL) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Cardiol Therapeutics Inc- foreign

Tip: Access up to 7 years of quarterly data

All positions including Cardiol Therapeutics Inc- foreign held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cardiol Therapeutics Inc- foreign by Barclays

Quarter filed Position value Share count Share price at filing
2026-03-31 $270 200 1.35

More positions owned by Barclays

Ishares Tr Opt Put Option (EEM)
Microsoft Corporation (MSFT)
STATE STR SPDR S&ampP 500 ETF T Opt Call Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Opt Call Option (QQQ)
Ishares Tr Fund (IWM)
Apple (AAPL)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Ishares Tr Opt Put Option (HYG)
JPMORGAN CHASE &amp Opt Call Option (JPM)
Alphabet Inc Class C cs (GOOG)

View all positions for Barclays

Top funds holding Cardiol Therapeutics Inc- foreign

MMCAP International Inc. SPC
Tejara Capital
Ikarian Capital
Citadel Advisors
Boothbay Fund Management
Two Sigma Investments
Integrity Alliance
Goldman Sachs Group
Morgan Stanley
Renaissance Technologies
Jane Street
Pvg Asset Management
Summit Financial
Knoll Capital Management
Goodman & Company, Investment Counsel

View all funds holding Cardiol Therapeutics Inc- foreign